Physician profile
Thomas Giancarlo
NPI 1780627018
$34,690.78
in general payments reported to CMS, 2019-2025
68 companies · $1,850 in 2025
The $1,850 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $2,809 · 2021: $1,287 · 2022: $93.55 · 2023: $134 · 2024: $617 · 2025: $1,850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,456 · Education: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,456.19 |
| Education | $145.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $26,692.77 | 2019-2025 | Uplizna |
| Genentech, INC. | $1,515.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $465.93 | 2019-2025 | |
| Ucb, INC. | $402.51 | 2019-2025 | Briviact, Fintepla, Nayzilam |
| Teva Pharmaceuticals USA, INC. | $345.35 | 2019-2025 | |
| Pfizer INC. | $342.98 | 2019-2025 | |
| Lilly USA, LLC | $309.24 | 2019-2022 | |
| Emd Serono, INC. | $306.20 | 2019-2025 | |
| Abbvie INC. | $306.14 | 2019-2025 | |
| Csl Behring | $230.97 | 2019-2025 | Hizentra |
| Genentech USA, INC. | $230.55 | 2019-2025 | Ocrevus Zunovo |
| Mdd US Operations, LLC | $213.20 | 2019-2020 | |
| Genzyme Corporation | $208.18 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $206.81 | 2019-2025 | Givlaari |
| Biogen, INC. | $202.16 | 2019-2025 | Vumerity, Skyclarys |
Show all 67 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Giancarlo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.